Startups
AffiGEN supplies research-use antibodies, ELISA kits, recombinant proteins, PCR controls, assay kits, cloning reagents and molecular biology products for life science laboratories worldwide.
Overview
Location
United States, Missouri, Saint Louis
Employees
1-10
Total raised
$17M
Founded date
2016
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 21, 2017 | Affigen Closes $17m Series A Financing | Affigen, a St. Louis, Missouri-based biotechnology company that develops therapeutics targeting cell lineage-specific tumor proteins, closed a $17m Series A financing. The round was led by Black Beret Life Sciences on behalf of its affiliat... |
Reviews 0
FAQ about Affigen
When was Affigen founded?
Affigen was founded in 2016.
How much funding has Affigen raised?
Affigen has raised $17M in total across 1 funding round.
What has the press written about Affigen?
Parsers VC has collected 2 articles mentioning Affigen, among them “Affigen Closes $17m Series A Financing” (Feb 21, 2017).
Is Affigen still active?
Affigen is probably closed: its latest activity on Parsers VC dates from Feb 22, 2017.